Hyderabad-based Biological-E will reserve 30 crore of COVID-19 vaccine doses after the Indian government decided to make an advance payment to the vaccine manufacturer.
These vaccine doses will be manufactured and stockpiled by Biological-E from August-December 2021. The health ministry will making an advance payment of Rs. 1500 crore to the company. Biological-E’s covid vaccine is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and could be available in the next few months.
Biological-E’s proposal for vaccine manufacturing in advance was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), the health ministry said in a statement.
News Source : NDTV
